Oncological emergencies Flashcards

1
Q

Criteria for neutropenic sepsis

A

Patient undergoing systemic anti cancer therapy
Temperature >38
Neutrophil <0.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When does neutropenic sepsis normally occur

A

10-14 days after systemic anticancer therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors for neutropenic sepsis

A
Prolonged neutropenia (>7 days)
Lower neutrophil count
Significant comorbidities
Progressive cancer
Central line in situ
Mucosal disruption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Frequent pathogens causing neutropenic sepsis

A
Staph aureus
Staph epidermidis 
Enterococcus
Streptococcus 
MRSA
VRE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Investigations for neutropenic sepsis

A
Bloods - FBC, U+Es, LFTs, CRP, lactate
Blood cultures
Urine dip
Sputum culture
Swabs of any lines and wounds
ABG
Imaging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Management of neutropenic sepsis

A
Empiric IV abx within 1 hour
Fluid resuscitation
Call SpR/consultant
Consider ITU
GCSF if severe (avoid in AML)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Changes to chemo cycles after neutropenic sepsis

A

Dose reduction
Prophylactic GCSF
Consider stopping chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How to prevent neutropenic sepsis

A

Patient education

Alert card

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What antibiotics are given for neutropenic sepsis

A

Meropenem
Tazocin
Vancomycin for suspected line infection
Gentamicin for hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathophysiology of metastatic spinal cord compression

A

90% Collapse or compression of a vertebral body with metastatic disease. 10% from primary tumour.
Cord compression causes oedema leading to venous congestion and demyelination (reversible)
Prolonged cord compression leads to vascular injury and cord necrosis (irreversible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Presentation of metastatic spinal cord compression

A

> 90% back pain
75% limb weakness
50% sensory level
40% bladder and anal sphincter dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the pain experienced in MSCC

A

Radicular or spinal

Exacerbated by straight leg raising, coughing, sneezing and straining

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Examination findings in MSCC

A
Acutely flaccid paralysis 
Hyperreflexia and hypertonia below level of compression 
Babinski reflex positive
Sensory loss below level of compression
Palpable bladder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of MSCC signs

A
Treatment within 24 hours!!
Admit
Bed rest - if severe back pain or MRI shows pedicle involvement 
MRI <24 hours
Dexamethasone 16mg 
PPI
Analgesia 
Surgery or supportive care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When should you seek advice before giving high dose dexamethasone

A

Lymphoma

Call haematology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When do you treat MSCC with supportive care

A
No motor function for >48 hours
Not fit for surgery - significant comorbidities 
Multiple spinal levels involved
Low performance status
Visceral mets 
Prognosis <3 months
17
Q

What is the supportive treatment for MSCC

A
Radiotherapy of abnormal vertebra + 1-2
Analgesia
Laxatives (cord compression, analgesia, poor mobility)
Bladder care
Monitor BMs (high dose steroids)
VTE prophylaxis 
PT/OT
18
Q

What is the definitive treatment for MSCC

A

Surgery to remove tumour from vertebral body and relieve cord compression
Re-stabilise spine

19
Q

How does radiotherapy work for MSCC

A

Causes cell death of rapidly dividing cells in the vertebra which relieves cord compression
Relieves pain

20
Q

Prognosis of MSCC

A

Median survival:
Not walking 1-3 months
Walking 5-8 months

21
Q

Causes of hypercalcaemia in cancer

A

80% paraneoplastic syndrome - PTHrP release
20% osteolytic mets - cytokine release
Lymphomas produce activated vitamin D

22
Q

Most common cancers to cause hypercalcaemia

A

Squamous cell e.g lung, renal, cervical, head+neck

Spread to bone - lung, myeloma, breast, thyroid, renal

23
Q

Common symptoms of hypercalcaemia

A
Thirst
Nausea
Anorexia
Constipation
Confusion
Polyuria
24
Q

Treatment of hypercalcaemia

A

Rehydration: at least 3 bags normal saline in 24 hours
Bisphosphonates: 60-90mg pamidronate IV

25
Q

What is tumour lysis syndrome

A

Massive tumour cell death leading to release of large amounts of potassium, phosphate and uric acid

26
Q

Electrolyte disturbances in tumour lysis syndrome

A
Hyperuricaemia 
Hyperkalaemia
Hyperphosphataemia
AKI
Hypocalcaemia
27
Q

Which tumours have a higher risk of tumour lysis syndrome

A

High grade lymphomas
Leukaemia
Bulky chemo-responsive tumours

28
Q

Patient risk factors for tumour lysis syndrome

A
Preexisting renal dysfunction
Preexisting hyperuricaemia
Pre-treatment high LDH
Hypovolaemia (pre-treatment diuretic use)
Urinary tract obstruction
29
Q

Presentation of tumour lysis syndrome

A
Day 3-7 post-chemo
N+V
Diarrhoea
Anorexia
Lethargy
Haematuria->Anuria
HF
Arrhythmia/cardiac arrest
30
Q

Prevention of tumour lysis syndrome

A
Pre-hydration
Vigorous hydration during treatment 
Monitor electrolytes 
Monitor fluid balance 
Allopurinol to reduce hyperuricaemia 
Rasburicase to convert uric acid to allantoin
31
Q

Treatment of tumour lysis syndrome if rasburicase doesn’t cure tumour lysis syndrome

A

Haemodialysis

32
Q

Causes of SVCO

A

80% lung cancer
10% lymphoma
5% SVC thrombus e.g central line

33
Q

Signs and symptoms of SVCO

A
SOB
Facial and neck swelling 
Plethoric face 
Trunk and upper limb swelling 
Dilated veins on chest wall 
Choking sensation
Chest pain 
Headache
Cough
Dyspnoea
Stridor
34
Q

Investigation for SVCO

A

CT with contrast

35
Q

Treatment for SVCO

A

Steroids frequently prescribed but no evidence for benefit
Stent if not radio/chemo-sensitive
Chemo - small cell lung cancer, lymphoma, teratoma
Radiotherapy - other malignant cancers